CY2281B1 - Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides - Google Patents
Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharidesInfo
- Publication number
- CY2281B1 CY2281B1 CY0200035A CY0200035A CY2281B1 CY 2281 B1 CY2281 B1 CY 2281B1 CY 0200035 A CY0200035 A CY 0200035A CY 0200035 A CY0200035 A CY 0200035A CY 2281 B1 CY2281 B1 CY 2281B1
- Authority
- CY
- Cyprus
- Prior art keywords
- polysaccharides
- pharmaceutical compositions
- compositions containing
- preparing same
- synthetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9607457A FR2749849B1 (fr) | 1996-06-14 | 1996-06-14 | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
CY2281B1 true CY2281B1 (en) | 2003-07-04 |
Family
ID=9493087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY0200035A CY2281B1 (en) | 1996-06-14 | 2002-05-15 | Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides |
Country Status (15)
Country | Link |
---|---|
US (1) | US7919614B2 (pt) |
EP (1) | EP0904299B1 (pt) |
JP (1) | JP3501813B2 (pt) |
AT (1) | ATE204883T1 (pt) |
AU (1) | AU3266797A (pt) |
BR (1) | BR9709722B1 (pt) |
CA (1) | CA2258146C (pt) |
CY (1) | CY2281B1 (pt) |
DE (1) | DE69706418T2 (pt) |
DK (1) | DK0904299T3 (pt) |
ES (1) | ES2163171T3 (pt) |
FR (1) | FR2749849B1 (pt) |
NO (1) | NO319037B1 (pt) |
PT (1) | PT904299E (pt) |
WO (1) | WO1997047659A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2751334B1 (fr) * | 1996-07-19 | 1998-10-16 | Sanofi Sa | Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2773804B1 (fr) * | 1998-01-19 | 2000-02-18 | Sanofi Sa | Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant |
EP1574516A1 (en) * | 2004-03-05 | 2005-09-14 | Sanofi-Aventis | Antithrombotic compound |
JP4796758B2 (ja) * | 2004-08-24 | 2011-10-19 | 学校法人 京都産業大学 | 組成物及びそれを含有する抗腫瘍剤 |
TWI403334B (zh) | 2004-12-23 | 2013-08-01 | Merck Sharp & Dohme | 包含生物素殘基之抗血栓雙重抑制劑 |
CN103333264B (zh) | 2008-05-30 | 2016-06-08 | 动量制药公司 | 糖结构以及制造和使用此类结构的方法 |
FR2949115B1 (fr) * | 2009-08-14 | 2012-11-02 | Sanofi Aventis | OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2949114B1 (fr) * | 2009-08-14 | 2011-08-26 | Sanofi Aventis | OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
FR2970969B1 (fr) * | 2011-01-27 | 2013-10-18 | Sanofi Aventis | Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique |
EP2578594A1 (en) * | 2011-10-04 | 2013-04-10 | Sanofi | Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction |
WO2021211441A1 (en) * | 2020-04-13 | 2021-10-21 | The Board Of Regents Of The University Of Oklahoma | Modified sugar polymers with low anticoagulant activity and therapeutic activity |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5382570A (en) * | 1990-04-23 | 1995-01-17 | Akzo, N.V. | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
US5529985A (en) * | 1990-04-23 | 1996-06-25 | Akzo Nobel Nv | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
US5668274A (en) * | 1991-04-23 | 1997-09-16 | Akzo Nobel N.V. | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
-
1996
- 1996-06-14 FR FR9607457A patent/FR2749849B1/fr not_active Expired - Fee Related
-
1997
- 1997-06-11 EP EP97928337A patent/EP0904299B1/fr not_active Expired - Lifetime
- 1997-06-11 DE DE69706418T patent/DE69706418T2/de not_active Expired - Lifetime
- 1997-06-11 JP JP50130798A patent/JP3501813B2/ja not_active Expired - Lifetime
- 1997-06-11 WO PCT/FR1997/001048 patent/WO1997047659A1/fr active IP Right Grant
- 1997-06-11 AT AT97928337T patent/ATE204883T1/de active
- 1997-06-11 CA CA002258146A patent/CA2258146C/fr not_active Expired - Lifetime
- 1997-06-11 PT PT97928337T patent/PT904299E/pt unknown
- 1997-06-11 BR BRPI9709722-5A patent/BR9709722B1/pt not_active IP Right Cessation
- 1997-06-11 AU AU32667/97A patent/AU3266797A/en not_active Abandoned
- 1997-06-11 ES ES97928337T patent/ES2163171T3/es not_active Expired - Lifetime
- 1997-06-11 DK DK97928337T patent/DK0904299T3/da active
-
1998
- 1998-12-11 NO NO19985831A patent/NO319037B1/no not_active IP Right Cessation
-
2002
- 2002-05-15 CY CY0200035A patent/CY2281B1/xx unknown
-
2003
- 2003-10-02 US US10/677,894 patent/US7919614B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1997047659A1 (fr) | 1997-12-18 |
BR9709722A (pt) | 2000-01-25 |
CA2258146A1 (fr) | 1997-12-18 |
DE69706418T2 (de) | 2002-05-29 |
BR9709722B1 (pt) | 2010-12-14 |
NO319037B1 (no) | 2005-06-06 |
PT904299E (pt) | 2002-02-28 |
JPH11513061A (ja) | 1999-11-09 |
EP0904299A1 (en) | 1999-03-31 |
AU3266797A (en) | 1998-01-07 |
DE69706418D1 (de) | 2001-10-04 |
EP0904299B1 (fr) | 2001-08-29 |
US7919614B2 (en) | 2011-04-05 |
DK0904299T3 (da) | 2001-12-17 |
ES2163171T3 (es) | 2002-01-16 |
NO985831L (no) | 1999-02-11 |
US20040068108A1 (en) | 2004-04-08 |
FR2749849B1 (fr) | 1998-09-04 |
ATE204883T1 (de) | 2001-09-15 |
NO985831D0 (no) | 1998-12-11 |
JP3501813B2 (ja) | 2004-03-02 |
FR2749849A1 (fr) | 1997-12-19 |
CA2258146C (fr) | 2003-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ333721A (en) | Pharmaceutically acceptable synthetic polysaccharides | |
CY2281B1 (en) | Synthetic polysaccharides method for preparing same and pharmaceutical compositions containing said polysaccharides | |
AU5935986A (en) | Microbial polysaccharide articles derived from acetobacter xylinum pellicle | |
IL86881A (en) | Polysaccharides extracted from plants,their preparation and pharmaceutical compositions containing them | |
CA2250153A1 (en) | Aldehyde-modified cellulosic fibers for paper products having high initial wet strength | |
ECSP930945A (es) | Metodo para la preparacion derivados carboximetilados | |
DE3485588D1 (de) | Chondroitin-sulfat/natriumhyaluronat-zusammensetzungen. | |
DE69116597D1 (de) | Proteinase-resistente Cellulase, sie produzierender Mikroorganismus und Verfahren zu ihrer Herstellung | |
ATE131176T1 (de) | Sulfatierte polysaccharide, antikoagulierungs- und antikomplementärmittel, hergestellt aus fukanen aus braunen algen, und verfahren zu deren herstellung. | |
NL300231I1 (nl) | Polyribosylribitolfosfaat omvattende entstofsamenstelling tegen haemophilus influenza type b en werkwijze voor de bereiding ervan. | |
EP0263703A3 (en) | Lactone modified, esterified or aminated additives useful in oleaginous compositions | |
MX9705002A (es) | Composicion de ensamblaje para hilos de vidrio, procedimiento que utiliza esta composicion y productos resultantes. | |
DE69805757D1 (de) | Polysaccharid, mikroorganismus und verfahren zu dessen herstellung, dieses enthaltende zusammensetzung und verwendung | |
IE782127L (en) | Microbial fractions. | |
ES8605041A1 (es) | Procedimiento de preparacion de polisacaridos membranarios de origen bacteriano | |
PT1020474E (pt) | Derivados de oligossacaridos e processo para a sua obtencao | |
CA2023058A1 (en) | Coating composition containing as thickeners polygalactomannans modified with hydrophilic and hydrophobic groups | |
CA2079018A1 (en) | Polysaccharide, its applications, its production by fermentation and the pseudomonas strain which produces it | |
ATE279445T1 (de) | Regioselektiv substituierte ester von oligo- und polysacchariden und verfahren zu ihrer herstellung | |
BR8806293A (pt) | Processo para a preparacao de diorganopolissiloxanos apresentando nas unidades terminais cada uma,um grupo hidroxila si-ligado | |
ES8505383A1 (es) | Procedimiento para la preparacion de sales de eritromicina, o sus esteres, con derivados acidos de la inosina | |
DE3780080D1 (de) | Coccidiozide mittel. | |
PL350611A1 (en) | Substituted polysaccharide sulfates, method for producing them and their use as high-performance flow agents for cement mixtures | |
DE69111119D1 (de) | Durch Fermentation hergestellte Polysaccharide. | |
GRUEN | ON POINT: CHOREOGRAPHIC INTERIORS FOR MARIA TALLCHIEF |